Skip to content
AnalystLens

Royalty Pharma Quarterly Report for Q3 Ended Sep 30, 2026

Filing Date
Filed November 4, 2026
Period End
September 30, 2026
Security
RPRX
In the record · 2020–202610-K610-Q208-K80

RPRX filed 6 annual reports (10-K), 20 quarterly reports (10-Q) and 80 current reports (8-K) between 2020 and 2026.

  1. Material agreement8-K · Jul ’21Jul ’21
  2. Impairment8-K · Dec ’22Dec ’22
  3. Leadership change8-K · Dec ’25Dec ’25

01—Abstract

A summary of this filing is not available yet.

02—Continue

← View all 10-Q filings